This is the distribution of shareholders from the 2024 AGM. I have posted this before:
The interesting group, for me, is the 10,001 to 100,000 group of 466 shareholders and 15.3% of shares. Perhaps some have already sold and have moved on, but this is a group with exposure between $74K and $740,00K, not an insignificant amount of money, and those who remain at vote time maybe highly motivated to vote and achieve a better outcome. Let's hope so.
Importance of your Vote
-For the proposed Scheme ofArrangement to pass it requires two important thresholds to be met:
- At least 75% of the total numberof shares voted at the scheme meeting must be in favour.
- More than 50% of the shareholderspresent and voting (in person or by proxy) must vote in favour.
I will be directing my proxy vote to the Chairman with instructions to Vote NO
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette
MYX
mayne pharma group limited
Add to My Watchlist
2.30%
!
$5.34

Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette, page-190
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.34 |
Change
0.120(2.30%) |
Mkt cap ! $429.7M |
Open | High | Low | Value | Volume |
$5.29 | $5.34 | $5.15 | $705.4K | 133.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | $5.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.34 | 3653 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | 5.310 |
1 | 864 | 5.290 |
1 | 28009 | 5.280 |
1 | 922 | 5.260 |
3 | 9131 | 5.250 |
Price($) | Vol. | No. |
---|---|---|
5.340 | 3653 | 3 |
5.350 | 16680 | 3 |
5.370 | 1631 | 1 |
5.390 | 1631 | 1 |
5.400 | 27852 | 4 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online